L Lugosi
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology 10
- Viral gastroenteritis research and epidemiology 2
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 8
- Immune responses and vaccinations 8
- Epidemiology top 10%
- Mycobacterium research and diagnosis 2
- Molecular Medicine top 10%
-
- Diagnosis and treatment of tuberculosis 2
-
- Child and Adolescent Health 2
-
- Transgenic Plants and Applications 2
- Co-authors
- William R. JacobsBarry R. BloomScott B. SnapperAntónia JekkelRachel E. MeltonTobias KieserNathalie PoissonU Quast
- Journals
- Proceedings of the National Academy of Sciences (1 paper)International Journal of Epidemiology (1 paper)Vaccine (2 papers)
- Partner nations
- United StatesVietnamHungary
In The Last Decade
L Lugosi
24 papers receiving 599 citations
Peers
Comparison fields: 5 of 70
- Infectious Diseases 412
- Immunology 263
- Epidemiology 327
- Molecular Medicine 43
- Ecology 109
Countries citing papers authored by L Lugosi
This map shows the geographic impact of L Lugosi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Lugosi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Lugosi more than expected).
Fields of papers citing papers by L Lugosi
This network shows the impact of papers produced by L Lugosi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Lugosi. The network helps show where L Lugosi may publish in the future.
Co-authorship network
The 13 scholars most cited alongside L Lugosi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [Statistically validated evaluation of clinical trials]. | 1999 | 1 |
| 2 | [Results of the BCG vaccination in Hungary since 1929: evaluation of preventive and immunotherapeutic effectiveness]. | 1998 | 3 |
| 3 | 1992 | 70 | |
| 4 | 1992 | 1 | |
| 5 | Standardized viability test required for preventive, immunomodulator and recombinant BCG vaccine. | 1992 | 2 |
| 6 | Transport and storage of vaccines in Hungary: the first cold chain monitor study in Europe. | 1990 | 39 |
| 7 | 1990 | 1 | |
| 8 | 1990 | 36 | |
| 9 | 1989 | 41 | |
| 10 | Development of genetic systems for the mycobacteria. | 1989 | 10 |
| 11 | 1988 | 262 | |
| 12 | Analysis of the efficacy of mass BCG vaccination from 1959 to 1983 in tuberculosis control in Hungary. Multiple comparison of results. | 1987 | 8 |
| 13 | Quantitative methods in the tuberculosis epidemiology and in the evaluation of BCG vaccination programs. | 1986 | 1 |
| 14 | Statistical quality control methods in standardization of BCG vaccines. | 1986 | 3 |
| 15 | 1985 | 4 | |
| 16 | 1984 | 7 | |
| 17 | Factors influencing the BCG policy in different countries. Children tuberculosis trends comparison between the Federal Republic of Germany and Hungary. | 1977 | 1 |
| 18 | [BCG and immunotherapy for tumors. Prevention of adverse effects of BCG vaccination]. | 1972 | 1 |
| 19 | BCG activity of the National Institute of Public Health: 1933-1970. Development of BCG vaccine production, control and results since 1959 in Hungary. | 1972 | 1 |
| 20 | The Capacity of the Saprophytic Bacteria to Tolerate H202 (shown by the Chance in Oxidation-reduction Potential), in Relation to Their Isoniazid Sensitivity and Catalase Activity. | 1959 | 1 |
About L Lugosi
L Lugosi is a scholar working on Infectious Diseases, Immunology and Toxicology, having authored 26 papers that have together received 647 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (10 papers), Immunodeficiency and Autoimmune Disorders (8 papers), Immune responses and vaccinations (8 papers), Viral gastroenteritis research and epidemiology (2 papers), Mycobacterium research and diagnosis (2 papers), Diagnosis and treatment of tuberculosis (2 papers), Child and Adolescent Health (2 papers) and Transgenic Plants and Applications (2 papers). The work is most often cited by research in Infectious Diseases (412 citations), Immunology (263 citations) and Epidemiology (327 citations). L Lugosi has collaborated with scholars based in United States, Vietnam and Hungary. Frequent co-authors include William R. Jacobs, Barry R. Bloom, Scott B. Snapper, Antónia Jekkel, Rachel E. Melton, Tobias Kieser, Nathalie Poisson, U Quast, A Lötte and O Wasz-Höckert. Their work appears in journals such as Proceedings of the National Academy of Sciences, International Journal of Epidemiology and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.